Viewing Study NCT05926492


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2026-05-12 @ 7:58 PM
Study NCT ID: NCT05926492
Status: RECRUITING
Last Update Posted: 2024-04-17
First Post: 2023-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2023-0425
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators